Chemoprevention in prostate cancer: Current perspective and future directions

J. Ricardo Rivero, Ian M. Thompson, Michael A. Liss, Dharam Kaushik

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Chemoprevention of prostate cancer aims to reduce the mortality as well as the public burden of overdetection, which increases anxiety, cost, and morbidity related to the disease. The role of 5-α-reductase inhibitors has been well investigated and shown to decrease the risk of prostate cancer. No current evidence exists to encourage the use of nutrients or vitamins as chemopreventive agents. The modulation of inflammation is one of the most promising targets for chemoprevention of prostate cancer.

Original languageEnglish (US)
Article numbera030494
JournalCold Spring Harbor Perspectives in Medicine
Issue number10
StatePublished - 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Chemoprevention in prostate cancer: Current perspective and future directions'. Together they form a unique fingerprint.

Cite this